Home » Topics » Nephrology, BioWorld Science

Nephrology, BioWorld Science
RSS

Vasopressin V2 receptor antagonist beneficial in mouse model of PKD

Nov. 13, 1998

VPA-985 characterized as potent, selective, orally active V2 antagonist

Nov. 13, 1998

Sepracor announces results of phase II pilot trial for (S)-oxybutynin

Nov. 13, 1998

RenaGel available this month in the U.S.

Nov. 11, 1998

Alza focuses on urology products; licenses Urispas

Nov. 4, 1998

U.S. grants first approval for GelTex's novel phosphate-binding polymer therapeutic

Nov. 3, 1998

Synthelabo team presents new agents for incontinence

Nov. 3, 1998

Basis of beneficial effects of cactus flower in BPH

Oct. 30, 1998

Milkhaus successfully completes phase II trial of BPH therapeutic

Oct. 21, 1998

Celsion ready to begin BPH treatment studies

Oct. 20, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 15, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Rethinking anorexia: A disorder of mind and metabolism
BioWorld Science
Anorexia nervosa (AN) is a complex and severe eating disorder that has long been considered a psychiatric condition driven by distorted body image and maladaptive...